Eurogin is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Welcome to the Multidisciplinary Forum on the Multifaceted Applications of AI in precancerous and cancerous pathologies of the cervical, anal, and oropharyngeal regions linked to HPV!
We are delighted to have you join this enlightening discussion, where we'll delve into the world of AI's diverse roles in screening, prediction, diagnostic support, and management of HPV-related precancerous and cancerous conditions. Let's explore the incredible potential of artificial intelligence in improving healthcare outcomes and shaping the future of cervical, anal, and oropharyngeal cancer management. Your insights and contributions are essential in this endeavour.
Invited Talk
AI in health care: general considerations
Digital imaging and AI: state of the art and road
N. Grabe (Germany)
Discussion
S. De Sanjosé (Spain)
I. Clinical implementation of AI-based solutions for cervical screening and management: opportunities and challenges
S. De Sanjosé (Spain)
II-1. Cervical screening
Self sampling and role of molecular markers
J. S. Smith (USA) •
C. Meijer (Netherlands)
Development and evaluation of Automated Visual Evaluation in LMIC
D. Egemen (USA)
II-2. AI solutions for triage and colposcopy
Colposcopy: enhancing image recognition of HG CIN
S. A. Madathil (Canada) •
J. Monsonego (France)
Automated detection of dual stain for triage of HPV-positives
N. Wentzensen (USA)
II-3. Anus
Detection of anal HSIL - Practical issues for AI solutions
L. Zhang (Australia)
II-4. Head and neck
Uncertainty quantification of AI-based prediction model and potential for clinical decision making
S. A. Madathil (Canada)
III. Conclusion
Moderators: E. Franco (Canada) • S. De Sanjosé (Spain) • N. Wentzensen (USA) • J. Monsonego (France)
Moving towards more personalised cervical cancer screening: determining differences in the risk of CIN2+ by age and HPV-type in Norway
A. Thorsplass (Norway)
Machine learning model for cervical cancer risk prediction
A. Garcia Serrano (Sweden)
Automated evaluation of p16/ki67 dual stain cytology as an artificial intelligence-based biomarker for detection of cervical intraepithelial neoplasia of grade 2 or worse in older HPV-positive women in cervical cancer screening - a cross sectional study
L. W. Gustafson (Denmark)
Risk stratified management of cervical high-grade squamous intraepithelial lesions based on machine learning
L. Zhang (China)
Cervix guide - a new artificial intelligence tool
A. Pacheco (Portugal)